Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiac surgery fluid therapy: 0.9% saline versus Plasma-Lyte 148
ACTRN12614000289617Phase 4Completed
- Sponsor
- Medical Research Institute of New Zealand
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of plasma-lyte and sodium chloride in cardiac surgery (2 arms), sponsored by Medical Research Institute of New Zealand. Primary endpoint: Chest tube output at 12 hours. Started Apr 2014; status: completed.
02
Drugs
plasma-lytesodium chloride
03
Conditions
cardiac surgery
Beyond the preview
Go deeper on ACTRN12614000289617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000289617.